Alan & Priscilla Oppenheimer Foundation: The Alan and Priscilla Oppenheimer Foundation seeks to advance humanity through scientific research and education. The foundation plans to leverage and enhance modern technology to improve the well-being of our species. The foundation has access to funds and expertise that can enable scientific research and education in the fields of genetics, molecular biology, computer science, and the intersections of these fields.

  Alan & Priscilla Oppenheimer Foundation
Autodesk: Autodesk, Inc., is a leader in 3D design, engineering and entertainment software. Customers across the manufacturing, architecture, building, construction, and media and entertainment industries – including the last 15 Academy Award winners for Best Visual Effects – use Autodesk software to design, visualize, and simulate their ideas. Since its introduction of AutoCAD software in 1982, Autodesk continues to develop the broadest portfolio of state-of-the-art software for global markets.   Autodesk
Center for Connected Health: The Center for Connected Health is working to create a new model for healthcare delivery, by developing programs and innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. Leveraging information technology -- cell phones, computers, networked devices, and simple remote health monitoring tools -- the Center is helping providers and patients manage chronic conditions, maintain health and wellness, and improve adherence, engagement and clinical outcomes. The Center for Connected Health is a division of Partners HealthCare in Boston, founded by Brigham and Women’s and Massachusetts General Hospitals.   Center for Connected Health

Clinical Future: Clinical Future’s mission is advancing the state of clinical applications of whole genome sequencing. Its partners and expert network have helped pioneer this emerging domain and hail from the Personal Genome Project, Harvard Medical School, Massachusetts General Hospital, Massachusetts Institute of Technology, and the Free Software Foundation. Clinical Future partners with clinical researchers and companies needing protocols, software development and analysis tools to bridge clinical genetics, next generation sequencing, bioinformatics, huge data sources and clinical-grade security.

  Clinical Future

Genentech: At Genentech, we're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That's why we use cutting-edge science to create and deliver innovative medicines around the globe.

  Genentech Inc

Genomic Arts: Genomic Arts, LLC is advancing genetics research by engaging the public in innovative ways - through games, art, and public events. Genomic Arts was founded by bioinformaticians Andrew Evans and Will FitzHugh with the backing of Maryland-based life sciences software powerhouse 5AM Solutions, and was the winner of the November 2011 Lean Startup Machine DC competition.

  Genomic Arts
Robinson Bradshaw & Hinson, P.A.: Our experienced life sciences attorneys provide results-oriented legal services for companies, investors, entrepreneurs and researchers throughout every stage of the business lifecycle. Our life sciences clients span a variety of industries including genetics and genomics, pharmaceuticals, biotechnology, biologics, personalized healthcare services, medical diagnostics, and food and nutritional supplements.   Robinson, Bradshaw, & Hinson
TeloMe: TeloMe (pronounced tella-me) is a leader in the emerging personal genomics industry. TeloMe serves both direct-to-consumer and institutional markets, providing high resolution telomere analysis and large-scale fulfillment services for collection and processing of saliva and other biological samples. TeloMe’s telomere analysis technologies incorporate the most desirable features of established, gold-standard technologies together with modern innovations to achieve unprecedented accuracy and throughput in the measurement and analysis of telomeres and associated DNA sequences at the ends of chromosomes.   TeloMe

23andMe: 23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science.

Wyss Institute: The Wyss Institute for Biologically Inspired Engineering at Harvard University uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Working as an alliance among Harvard's Schools of Medicine, Engineering, and Arts & Sciences, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, and Boston University, the Institute crosses disciplinary and institutional barriers to engage in high-risk research that leads to transformative technological breakthroughs. By emulating Nature's principles for self-organizing and self-regulating, Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing. These technologies are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and new start-ups.   Wyss Institute

Limited sponsorship opportunities are still available.
For more information, please write: jason@personalgenomes.org






Organizing Sponsors


Harvard Medical School